Medicine recalls
|
| |
| The United States: PDX Aromatics issues second expanded recall of kratom products because of possible health risk |
| |
The US Food and Drug Administration (FDA) announces that PDX Aromatics, DBA Kraken Kratom, Phytoextractum, and Soul Speciosa, is again expanding the scope of their 3/9/2018 and 3/15/2018 voluntary recalls to include certain red vein and green vein kratom powder and capsule products because they have the potential to be contaminated with Salmonella. The second expanded recall is being initiated in response to additional positive findings of Salmonella associated with PDX Aromatics’ products following the FDA’s investigation.
PDX Aromatics has identified multiple suppliers in their supply chain as the sources of Salmonella. The company has removed additional suppliers from their supply chain, is resolving potential sources of contamination in its supply, and is removing all affected products.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm602438.htm
In Hong Kong, the above products are not registered pharmaceutical products. There is also no registered pharmaceutical product containing kratom. Related news was previously issued by FDA, and was posted on the Drug Office website on 12 Mar 2018 and 19 Mar 2018.
Ends/Saturday, March 24, 2018
Issued at HKT 12:30
|
| |
|
